| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,500 | 06 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JSPR | Jasper Therapeutics, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 18:30 |
| JSPR | Jasper Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 18:41 |
| JSPR | Jasper Therapeutics, Inc. | 14 Apr 2023 | 1 | -$10,360 | 4 | Director | 14 Apr 2023, 16:19 |
| JSPR | Jasper Therapeutics, Inc. | 12 Oct 2022 | 1 | $0 | 4 | Director | 13 Oct 2022, 19:56 |
| JSPR | Jasper Therapeutics, Inc. | 21 Mar 2022 | 1 | $0 | 4 | Director | 23 Mar 2022, 18:00 |
| JSPR | Jasper Therapeutics, Inc. | 24 Sep 2021 | 0 | $0 | 3 | Director | 01 Oct 2021, 16:08 |